CD19-Directed CAR T-Cells (CD19-CAR) Combined with Acalabrutinib Achieves Durable Remissions in Patients with Relapsed or Refractory (r/r) Mantle Cell Lymphoma (MCL)John H. Baird,Marissa Morales Del Real,Joo Y. Song,Geoffrey P. Shouse,Alexey Danilov,Alex F. Herrera,Leslie L. Popplewell,Steven T. Rosen, Jennifer Davis,Baishakhi Barva,Lu Chen,Larry W. Kwak, Stephen J. Forman,L. Elizabeth BuddeBLOOD(2023)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要